InsiderSignal.AI

InsiderSignal.ai

BCAX - Bicara Therapeutics Inc.

Insider Purchase by Ra Capital Management, L.P. (Dir, 10%)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Ra Capital Management, L.P., serving as Dir, 10% owner at Bicara Therapeutics Inc. (BCAX), purchased 300,000 shares at $16.00 per share, for a total transaction value of $4,800,000.00. Following this transaction, Ra Capital Management, L.P. now holds 7,255,993 shares of BCAX.

This purchase represents a 4.00% increase in Ra Capital Management, L.P.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, February 26, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 2, 2026, 4 days after the trade was made.

Bicara Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Ra Capital Management, L.P.

Ra Capital Management, L.P.

Dir, 10%

RA Capital Management, L.P. is a Boston-based investment firm specializing in public and private investments in healthcare, biotechnology, life sciences, and planetary health.[[1]](https://en.wikipedia.org/wiki/RA_Capital_Management)[[2]](https://www.racap.com/about-us) Founded in 2001 by Richard Aldrich, a co-founder of Vertex Pharmaceuticals, the firm officially launched in 2004 as a hedge fund focused on public companies before expanding into private investments, company formation, and venture funding.[[1]](https://en.wikipedia.org/wiki/RA_Capital_Management)[[2]](https://www.racap.com/about-us) The firm manages approximately $5.94 billion in assets as of mid-2025, with a portfolio spanning global therapeutic areas and development stages, including top holdings like Ascendis Pharma (29.9%) and Vaxcyte (6.55%).[[3]](https://whalewisdom.com/filer/ra-capital-management-llc) RA Capital has launched multiple venture funds, such as Nexus Fund III ($880 million in 2021), and operates incubators like Carnot and RAVentures to nurture early-stage biotech companies.[[1]](https://en.wikipedia.org/wiki/RA_Capital_Management)[[2]](https://www.racap.com/about-us) As a corporate insider designated as 'Dir, 10%' at Climb Bio, Inc. (CLYM), it holds significant stakes through affiliates like Sera Medicines, LLC, reflecting its active role in biotech investments.[[3]](https://whalewisdom.com/filer/ra-capital-management-llc)

View full insider profile →

Trade Price

$16.00

Quantity

300,000

Total Value

$4,800,000.00

Shares Owned

7,255,993

Trade Date

Thursday, February 26, 2026

7 days ago

SEC Filing Date

Monday, March 2, 2026

Filed 4 days after trade

HEALTHCAREBIOTECHNOLOGY

About Bicara Therapeutics Inc.

Company Overview

No company information available
View news mentioning BCAX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4439452

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime